Back
Calidi Biotherapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
41
CLDI
Calidi Biotherapeutics
Last Price:
1.20
Seasonality Move:
-29.17%
Sell
49
NBY
NovaBay Pharmaceuticals
Last Price:
0.70
Seasonality Move:
-22.66%
Sell
41
Calidi Biotherapeutics (CLDI)
is a Sell
Is Calidi Biotherapeutics a Buy, Sell or Hold?
- The current Calidi Biotherapeutics [CLDI] share price is $1.21. The Score for CLDI is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- CLDI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.71. The Score for NBY is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CLDI Stock Price Chart
What is Calidi Biotherapeutics's stock price today?
-
The Calidi Biotherapeutics share price today is $1.21
The current trend is relatively stagnant and CLDI is experiencing buying pressure, which is a positive indicator for future bullish movement.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.71
The current trend is relatively stagnant and NBY is experiencing slight buying pressure.
CLDI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 48.03 | Sell |
Chaikin Money Flow: | 93304 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.12 - 1.18) | Buy |
Bollinger Bands (100): | (1.28 - 2.18) | Sell |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0 | Buy |
Relative Strength Index (14 RSI): | 57.14 | Buy |
Chaikin Money Flow: | 63291 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.44 - 0.64) | Buy |
Bollinger Bands (100): | (0.44 - 3.24) | Sell |
CLDI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.15 | Buy |
20-day SMA: | 1.15 | Buy |
50-day SMA: | 1.38 | Sell |
200-day SMA: | 5.07 | Sell |
8-day EMA: | 1.17 | Buy |
20-day EMA: | 1.19 | Buy |
50-day EMA: | 1.42 | Sell |
200-day EMA: | 11.49 | Sell |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.67 | Buy |
20-day SMA: | 0.55 | Buy |
50-day SMA: | 0.69 | Buy |
200-day SMA: | 3.51 | Sell |
8-day EMA: | 0.67 | Buy |
20-day EMA: | 0.61 | Buy |
50-day EMA: | 0.9 | Sell |
200-day EMA: | 7.9 | Sell |
Calidi Biotherapeutics Earnings Growth & CLDI Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.72 per share, and an increase next year of $0.29 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $13.87 per share, an increase next quarter of $0.05 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.
Calidi Biotherapeutics Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |